DE69527442D1 - Verfahren zur behandlung von wahrnehmungsstörungen - Google Patents

Verfahren zur behandlung von wahrnehmungsstörungen

Info

Publication number
DE69527442D1
DE69527442D1 DE69527442T DE69527442T DE69527442D1 DE 69527442 D1 DE69527442 D1 DE 69527442D1 DE 69527442 T DE69527442 T DE 69527442T DE 69527442 T DE69527442 T DE 69527442T DE 69527442 D1 DE69527442 D1 DE 69527442D1
Authority
DE
Germany
Prior art keywords
treating
perceptional
disorders
methyl
benzodiazepine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69527442T
Other languages
English (en)
Other versions
DE69527442T2 (de
Inventor
M Beasley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Priority claimed from CA002219902A external-priority patent/CA2219902A1/en
Publication of DE69527442D1 publication Critical patent/DE69527442D1/de
Application granted granted Critical
Publication of DE69527442T2 publication Critical patent/DE69527442T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Processing Of Meat And Fish (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Light Receiving Elements (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
DE69527442T 1995-05-30 1995-05-30 Verfahren zur behandlung von wahrnehmungsstörungen Expired - Fee Related DE69527442T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002219902A CA2219902A1 (en) 1995-05-30 1995-05-30 Use of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno¬2,3b|¬1,5|benzodiazepine for treating cognitive dysfunction
PCT/US1995/006859 WO1996038151A1 (en) 1995-05-30 1995-05-30 Method for treating cognitive dysfunction

Publications (2)

Publication Number Publication Date
DE69527442D1 true DE69527442D1 (de) 2002-08-22
DE69527442T2 DE69527442T2 (de) 2003-02-20

Family

ID=25679786

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69527442T Expired - Fee Related DE69527442T2 (de) 1995-05-30 1995-05-30 Verfahren zur behandlung von wahrnehmungsstörungen

Country Status (17)

Country Link
EP (1) EP0828494B1 (de)
JP (1) JPH11506096A (de)
AT (1) ATE220550T1 (de)
AU (1) AU707858B2 (de)
CZ (1) CZ292565B6 (de)
DE (1) DE69527442T2 (de)
DK (1) DK0828494T3 (de)
ES (1) ES2180643T3 (de)
FI (1) FI973987A (de)
HK (1) HK1009393A1 (de)
HU (1) HUT77907A (de)
MX (1) MX9707936A (de)
NO (1) NO318553B1 (de)
NZ (1) NZ288037A (de)
PL (1) PL189714B1 (de)
PT (1) PT828494E (de)
WO (1) WO1996038151A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
UA57727C2 (uk) * 1996-03-11 2003-07-15 Елі Ліллі Енд Компані Спосіб лікування надмірної агресивності
PL196814B1 (pl) * 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
WO2005070938A1 (en) 2004-01-27 2005-08-04 Synthon B.V. Stable salts of olanzapine
US7932249B2 (en) 2005-01-05 2011-04-26 Eli Lilly And Company Olanzapine pamoate dihydrate
PL381564A1 (pl) 2007-01-22 2008-08-04 Koźluk Tomasz Nobilus Ent Sposób wytwarzania zasadniczo czystej odmiany polimorficznej I olanzapiny

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270464A (en) * 1989-03-14 1993-12-14 Janssen Pharmaceutica N.V. Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
AU707858B2 (en) 1999-07-22
DE69527442T2 (de) 2003-02-20
EP0828494A4 (de) 1999-11-24
MX9707936A (es) 1997-12-31
PL189714B1 (pl) 2005-09-30
HUT77907A (hu) 1998-10-28
EP0828494A1 (de) 1998-03-18
NO318553B1 (no) 2005-04-11
ES2180643T3 (es) 2003-02-16
FI973987A0 (fi) 1997-10-17
WO1996038151A1 (en) 1996-12-05
FI973987A (fi) 1997-10-17
PT828494E (pt) 2002-10-31
NO974766D0 (no) 1997-10-15
AU2693695A (en) 1996-12-18
JPH11506096A (ja) 1999-06-02
NZ288037A (en) 1999-09-29
HK1009393A1 (en) 1999-06-04
NO974766L (no) 1997-12-09
DK0828494T3 (da) 2002-09-02
ATE220550T1 (de) 2002-08-15
CZ324397A3 (cs) 1998-08-12
EP0828494B1 (de) 2002-07-17
PL323785A1 (en) 1998-04-27
CZ292565B6 (cs) 2003-10-15

Similar Documents

Publication Publication Date Title
MY114701A (en) Process and crystal forms of 2-methyl-thieno- benzodiazepine
NO961483D0 (no) Fremgangsmåte for behandling av oljeholdig formasjon
IL148071A0 (en) Method for treatment of symptoms of central nervous system disorders
DE69626864D1 (de) Abwasserbecken ZUR AEROBEN BEHANDLUNG VON ABWASSER beinhaltend Träger
DE60336226D1 (de) Verfahren zur herstellung von olanzapin form i
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
IL117971A0 (en) Method for treating dyskinesias
DE69527442D1 (de) Verfahren zur behandlung von wahrnehmungsstörungen
HU9601889D0 (en) Method for biological treatment of waters
NO982911L (no) FremgangsmÕte for behandling av depresjon
TW429149B (en) Pharmaceutical composition for treating conditions resulting from the cessation and withdrawal from the use of nicotine
ZA969721B (en) Method of treating sepsis.
IL128028A0 (en) Treatment of psychotic disorders
DK0831835T3 (da) Behandling af anorexia
NZ324615A (en) Method for treating autism using olanzapine
DK0877818T3 (da) Fremgangsmåde til aktivering af en kinase
HUP9902882A2 (hu) Olanzapin alkalmazása álmatlanság kezelésére szolgáló gyógyszerkészítmények előállítására
NZ331846A (en) Method for preparing a medicament using olanzapine for treating insomnia
HUT75854A (en) Method for treating of tiocarbamat waste waters
HUT76735A (en) Method for treatment of sludges
HUT76738A (en) Method for treating of high fat contain waters

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee